Stock NAUT NAUTILUS BIOTECHNOLOGY, INC.
Add to a list
To use this feature you must be a member
Log inSign up

All News Nautilus Biotechnology, Inc.

Equities

NAUT

US63909J1088

Real-time Estimate Cboe BZX
Other stock markets
 03:36:00 2024-04-25 pm EDT 		5-day change 1st Jan Change
2.385 USD -0.63% Intraday chart for Nautilus Biotechnology, Inc. +2.56% -19.73%
Feb. 28 Transcript : Nautilus Biotechnology, Inc., Q4 2023 Earnings Call, Feb 28, 2024
Feb. 28 Nautilus Biotechnology, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 CI

All News

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Nautilus Biotechnology to Announce First Quarter 2024 Financial Results on April 30, 2024
GL
Nautilus Biotechnology to Announce First Quarter 2024 Financial Results on April 30, 2024
AQ
Transcript : Nautilus Biotechnology, Inc., Q4 2023 Earnings Call, Feb 28, 2024
Nautilus Biotechnology Reports Fourth Quarter and Fiscal Year 2023 Financial Results
GL
Nautilus Biotechnology, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023
CI
Nautilus Biotechnology, Inc. Reports Earnings Results for the Fourth Quarter Ended December 31, 2023
CI
Nautilus Biotechnology to Participate in the TD Cowen 44ᵗʰ Annual Healthcare Conference
GL
Nautilus Biotechnology to Participate in the TD Cowen 44ᵗʰ Annual Healthcare Conference
AQ
Nautilus Biotechnology to Announce Fourth Quarter and Full Year 2023 Financial Results on February 28, 2024
GL
Nautilus Biotechnology Co-founder and Chief Scientist Parag Mallick, Ph.D., Honored with US HUPO Computational Proteomics Award
GL
Nautilus Biotechnology Co-founder and Chief Scientist Parag Mallick, Ph.D., Honored with US HUPO Computational Proteomics Award
AQ
Nautilus Biotechnology Appoints Martin Huber, Ph.D., as Vice President of Biochemistry and Flow Cell Development
GL
Transcript : Nautilus Biotechnology, Inc., Q3 2023 Earnings Call, Oct 31, 2023
Nautilus Biotechnology Reports Third Quarter 2023 Financial Results
GL
Nautilus Biotechnology, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023
CI
Nautilus Biotechnology : Reports Third Quarter 2023 Financial Results - Form 8-K
PU
Nautilus Biotechnology to Announce Third Quarter Financial Results on October 31, 2023
GL
Nautilus Biotechnology to Announce Third Quarter Financial Results on October 31, 2023
AQ
Transcript : Nautilus Biotechnology, Inc. Presents at Morgan Stanley 21st Annual Global Healthcare Conference 2023, Sep-13-2023 10:50 AM
Nautilus Biotechnology to Participate in Upcoming September Investor Conferences
GL
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. NAUT Stock
  4. News Nautilus Biotechnology, Inc.